Obesity in patients with end-stage heart failure

被引:1
|
作者
Krol, Bogumila [1 ]
Oprzedkiewicz, Aleksandra [2 ]
Szczurek, Wioletta [2 ]
Szygula-Jurkiewicz, Bozena [3 ]
机构
[1] Silesian Ctr Heart Dis, Off Transplant Coordinat, Dept Cardiosurg Transplantol Vasc & Endovasc Surg, Zabrze, Poland
[2] Med Univ Silesia, Sch Med, Dept Cardiol 3, Div Dent Zabrze,Student Sci Soc, Katowice, Poland
[3] Med Univ Silesia, Sch Med, Dept Cardiol 3, Div Dent Zabrze, Katowice, Poland
来源
关键词
obesity; end-stage heart failure;
D O I
10.5114/kitp.2018.78442
中图分类号
R61 [外科手术学];
学科分类号
摘要
Obesity poses an increasing problem in patients with end-stage heart failure (HF). The most commonly used indicator of obesity is body mass index. The value of this parameter is widely taken into consideration when selecting the best way of treatment for patients with advanced HF. The aim of this paper is to outline the recent knowledge about obesity in the abovementioned group of patients.
引用
收藏
页码:176 / 179
页数:4
相关论文
共 50 条
  • [21] MitraClip® therapy in patients with end-stage systolic heart failure
    Franzen, Olaf
    van der Heyden, Jan
    Baldus, Stephan
    Schlueter, Michael
    Schillinger, Wolfgang
    Butter, Christian
    Hoffmann, Rainer
    Corti, Roberto
    Pedrazzini, Giovanni
    Swaans, Martin J.
    Neuss, Michael
    Rudolph, Volker
    Suerder, Daniel
    Gruenenfelder, Juerg
    Eulenburg, Christine
    Reichenspurner, Hermann
    Meinertz, Thomas
    Auricchio, Angelo
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (05) : 569 - 576
  • [22] MitraClip implantation in patients with end-stage systolic heart failure
    Fiorelli, F.
    Giannini, C.
    De Carlo, M.
    Petronio, A. S.
    Tamburino, C.
    Capodanno, D.
    Ettori, F.
    Fiorina, C.
    Bedogni, F.
    Brambilla, N.
    EUROPEAN HEART JOURNAL, 2014, 35 : 694 - 694
  • [23] Differentiated approach to the treatment of patients with end-stage heart failure
    Shatova, O. Olesya
    Kurlianskaya, A.
    Rachok, L.
    Ostrovsky, Y.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 378 - 379
  • [25] Testing the obesity paradox in patients on long-term milrinone infusion for end-stage heart failure
    Benjamin, Mina M.
    Sundararajan, Sakthi
    Sulaiman, Samian
    Kindel, Tammy
    Joyce, David
    Mohammed, Asim A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2019, 9 (04): : 59 - 64
  • [26] Combined heart and kidney transplantation in patients with end-stage heart and kidney failure
    Khush, K. K.
    Bhalla, V.
    Rifkin, C.
    McGlothlin, D.
    Vincenti, F.
    Hoopes, C.
    De Marco, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S56 - S56
  • [27] Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure
    Leeser, DB
    Jeevanandam, V
    Furukawa, S
    Eisen, H
    Mather, P
    Silva, P
    Guy, S
    Foster, CE
    AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (01) : 89 - 92
  • [28] The surgical treatment of end-stage heart failure
    Blom, Aaron S.
    Acker, Michael A.
    CURRENT PROBLEMS IN CARDIOLOGY, 2007, 32 (10) : 553 - 599
  • [29] Apoptosis in myocytes in end-stage heart failure
    Narula, J
    Haider, N
    Virmani, R
    DiSalvo, TG
    Kolodgie, FD
    Hajjar, RJ
    Schmidt, U
    Semigran, MJ
    Dec, GW
    Khaw, BA
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16): : 1182 - 1189
  • [30] Dobutamine and mortality in end-stage heart failure
    Ebell, M
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (04) : 756 - 756